CYTK
Cytokinetics Inc.#80 · 2021EPBYearly return
+95%
Peak return
+105%
Max drawdown
-32%
ADR (20 days)
+5.9%
Base
15 days / -23.9%
Prior run
+15%
Breakout volume
52.7x
Pivot
$23.28
Catalyst Analysten/Re-Rating2021-07-19Analysts See Higher Success Chances For Cytokinetics' Heart Disease Candidate After Positive Phase 2 DataBenzinga
Analysten- oder Re-Rating-Impuls, oft mit Momentum-Folgekaeufern.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare CYTK with the current market directly.